Alberto Chiappori

机构：Moffitt Cancer Center · ORCID：0000-0003-0810-7104

发表论文 257 篇 · 总被引 17092 次 · h-index 49

代表论文

• Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study (2024 · Lung Cancer · 被引 9)
• NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING (2025 · Journal of Clinical Investigation · 被引 8)
• Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation (2023 · Journal of Thoracic Disease · 被引 8)
• Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use (2025 · Clinical Lung Cancer · 被引 7)
• Safety, tolerability, and preliminary efficacy results of a phase 1 study of LB2102, a dnTGFβRII armored DLL3-targeted autologous CAR-T cell therapy, in patients with relapsed or refractory small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC). (2025 · Journal of Clinical Oncology · 被引 6)
• Alisertib in patients with extensive-stage small-cell lung cancer: The phase 2 ALISCA-Lung1 study. (2024 · Journal of Clinical Oncology · 被引 4)